Infections Hepatitis B

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Hepatitis B Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Hepatitis B Projects
--Benesis Corporation
--Achillion Pharmaceuticals Inc
--Dynavax Technologies Corp
--Bukwang Pharmaceutical Company Limited
--Enzo Biochem Inc
--Emergent BioSolutions Inc
--Gilead Sciences Inc
--Genexine Co., Ltd.
--Medivir AB
--LG Life Sciences Ltd.
--Nabi Biopharmaceuticals
--Merck & Co Inc
--Pharmasset, Inc.
--Oxford BioMedica plc
--RFS Pharma, LLC
--Phytrix Inc.
--Vion Pharmaceuticals Inc
--Romark Laboratories, L.C.

--Top Companies in early stage Hepatitis B Projects
--Beijing Pason Pharmaceuticals Inc
--Avexa Limited
--CEL-SCI Corporation
--Can-Fite BioPharma, Ltd.
--Dynavax Technologies Corp
--Dong-A Pharmaceutical Co., Ltd.
--Hemispherx Biopharma Inc
--GenPhar, Inc.
--Luitpold Pharmaceuticals, Inc.
--Innogenetics
--Molecules for Health, Inc.
--Merck & Co Inc
--Nautilus Biotech
--NanoBio Corporation
--Pfizer Inc
--Nucleonics, Inc
--Protiva Biotherapeutics Inc
--Pharmexa A/S
--Virax Holdings Limited
--Romark Laboratories, L.C.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View